A study of BGE-102 for obesity and heart risk
Part of Hormones & metabolism clinical trials.
This trial tests an experimental drug called BGE-102 in people with obesity and signs of inflammation. It aims to see if the drug can help reduce body weight and improve heart health. Participants must be willing to keep a stable diet and exercise routine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with a body mass index (BMI) between 32 and 42 kg/m²
- You have elevated levels of hsCRP, a blood test marker for inflammation
- You have at least one heart risk factor or sign of metabolic syndrome (like high blood pressure, high cholesterol, or prediabetes)
- You are not taking weight-loss medications or programs, and have not gained or lost more than 5% of your body weight recently
- You do not have type 1 diabetes, uncontrolled type 2 diabetes, or uncontrolled high blood pressure or high cholesterol
- You are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation affects heart disease and diabetes. It may help find new ways to prevent or treat these conditions.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.
This trial tests an investigational drug called SGB-7342 to see if it helps with weight loss in people who are overweight or have obesity. It might be an option if you have a stable weight and haven't used certain weight-loss medications recently.
Hear when a new Obesity and Cardiovascular Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.